Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Treasury Shares (2021 - 2025)

Biofrontera has reported Treasury Shares over the past 5 years, most recently at $412500.0 for Q4 2025.

  • For Q4 2025, Treasury Shares fell 8.33% year-over-year to $412500.0; the TTM value through Dec 2025 reached $412500.0, down 8.33%, while the annual FY2025 figure was $412500.0, 8.33% down from the prior year.
  • Treasury Shares for Q4 2025 was $412500.0 at Biofrontera, roughly flat from $412500.0 in the prior quarter.
  • Over five years, Treasury Shares peaked at $343.5 million in Q2 2022 and troughed at $4771.0 in Q2 2023.
  • A 5-year average of $23.1 million and a median of $343512.0 in 2022 define the central range for Treasury Shares.
  • Biggest five-year swings in Treasury Shares: tumbled 100.0% in 2023 and later soared 9331.98% in 2024.
  • Year by year, Treasury Shares stood at $8504.0 in 2021, then skyrocketed by 101.98% to $17176.0 in 2022, then plummeted by 72.22% to $4771.0 in 2023, then soared by 9331.98% to $450000.0 in 2024, then fell by 8.33% to $412500.0 in 2025.
  • Business Quant data shows Treasury Shares for BFRI at $412500.0 in Q4 2025, $412500.0 in Q3 2025, and $450000.0 in Q2 2025.